Back to GetFilings.com



Table of Contents

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


FORM 10-Q

(Mark One)

     
þ   QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended March 31, 2004

OR

     
o   TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from                      to

Commission file number 0-26844

RADISYS CORPORATION

(Exact name of registrant as specified in its charter)
     
OREGON
(State or other jurisdiction of
Incorporation or Organization)
  93-0945232
(I.R.S. Employer
Identification Number)

5445 N.E. Dawson Creek Drive
Hillsboro, OR 97124

(Address of principal executive offices, including zip code)

(503) 615-1100
(Registrant’s telephone number, including area code)

     Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to the filing requirements for the past 90 days. Yes þ No o

     Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Act) Yes þ No o

     Number of shares of Common Stock outstanding as of April 30, 2004: 18,740,339

 


RADISYS CORPORATION
FORM 10-Q

TABLE OF CONTENTS

         
    Page
       
       
    2  
    3  
    4  
    5  
    6  
    19  
    35  
    37  
       
    37  
    38  
 EXHIBIT 10.1
 EXHIBIT 31.1
 EXHIBIT 31.2
 EXHIBIT 32.1
 EXHIBIT 32.2

1


Table of Contents

PART I. FINANCIAL INFORMATION

Item 1. Consolidated Financial Statements

RADISYS CORPORATION

CONSOLIDATED STATEMENTS OF OPERATIONS

(In thousands, except per share amounts, unaudited)
                 
    For the Three Months Ended March 31,
    2004
  2003
Revenues
  $ 61,115     $ 48,404  
Cost of sales
    42,297       33,207  
 
   
 
     
 
 
Gross margin
    18,818       15,197  
Research and development
    6,344       5,540  
Selling, general, and administrative
    7,677       6,548  
Intangible assets amortization
    682       765  
Restructuring charges (reversals)
    (180 )     1,829  
 
   
 
     
 
 
Income from operations
    4,295       515  
Gain on repurchase of convertible subordinated notes
          825  
Interest expense
    (1,426 )     (1,209 )
Interest income
    856       803  
Other income (expense), net
    78       (492 )
 
   
 
     
 
 
Income from continuing operations before income tax provision
    3,803       442  
Income tax provision
    955       9  
 
   
 
     
 
 
Income from continuing operations
    2,848       433  
Discontinued operations related to Savvi business:
               
Loss from discontinued operations
          (4,679 )
 
   
 
     
 
 
Net income (loss)
  $ 2,848     $ (4,246 )
 
   
 
     
 
 
Income per share from continuing operations:
               
Basic
  $ 0.15     $ 0.02  
 
   
 
     
 
 
Diluted
  $ 0.15     $ 0.02  
 
   
 
     
 
 
Net income (loss) per share:
               
Basic
  $ 0.15     $ (0.24 )
 
   
 
     
 
 
Diluted
  $ 0.15     $ (0.24 )
 
   
 
     
 
 
Weighted average shares outstanding:
               
Basic
    18,491       17,673  
 
   
 
     
 
 
Diluted
    19,447       17,840  
 
   
 
     
 
 

The accompanying notes are an integral part of these financial statements.

2


Table of Contents

RADISYS CORPORATION

CONSOLIDATED BALANCE SHEETS

(In thousands, unaudited)
                 
    March 31,   December 31,
    2004
  2003
ASSETS
               
Current assets:
               
Cash and cash equivalents
  $ 168,957     $ 149,925  
Short-term investments, net
    41,629       44,456  
Accounts receivable, net
    36,791       32,144  
Inventories, net
    21,523       26,092  
Other current assets
    2,800       2,781  
Deferred tax assets
    6,898       6,898  
 
   
 
     
 
 
Total current assets
    278,598       262,296  
Property and equipment, net
    14,526       14,584  
Goodwill
    27,521       27,521  
Intangible assets, net
    5,755       6,437  
Long-term investments, net
    23,859       30,992  
Long-term deferred tax assets
    22,017       21,911  
Other assets
    1,959       1,821  
 
   
 
     
 
 
Total assets
  $ 374,235     $ 365,562  
 
   
 
     
 
 
LIABILITIES AND SHAREHOLDERS’ EQUITY
               
Current liabilities:
               
Accounts payable
  $ 24,068     $ 21,969  
Accrued wages and bonuses
    4,921       4,868  
Accrued interest payable
    979       1,577  
Accrued restructuring
    2,174       2,820  
Other accrued liabilities
    8,399       8,738  
 
   
 
     
 
 
Total current liabilities
    40,541       39,972  
 
   
 
     
 
 
Long-term liabilities:
               
Convertible senior notes, net
    97,047       97,015  
Convertible subordinated notes, net
    67,657       67,585  
 
   
 
     
 
 
Total long-term liabilities
    164,704       164,600  
 
   
 
     
 
 
Total liabilities
    205,245       204,572  
 
   
 
     
 
 
Shareholders’ equity :
               
Common stock — no par value, 100,000 shares authorized; 18,644 and 18,274 shares issued and outstanding at March 31, 2004 and December 31, 2003
    171,757       166,445  
Accumulated deficit
    (5,846 )     (8,694 )
Accumulated other comprehensive income:
               
Cumulative translation adjustments
    3,079       3,239  
 
   
 
     
 
 
Total shareholders’ equity
    168,990       160,990  
 
   
 
     
 
 
Total liabilities and shareholders’ equity
  $ 374,235     $ 365,562  
 
   
 
     
 
 

The accompanying notes are an integral part of these financial statements.

3


Table of Contents

RADISYS CORPORATION

CONSOLIDATED STATEMENT OF CHANGES IN SHAREHOLDERS’ EQUITY

(In thousands, unaudited)
                                                 
    Common Stock   Cumulative                   Total other
   
  translation   Accumulated           comprehensive
    Shares
  Amount
  adjustments(1)
  deficit
  Total
  income (loss) (2)
Balances, December 31, 2003
    18,274     $ 166,445     $ 3,239     $ (8,694 )   $ 160,990          
Shares issued pursuant to benefit plans.
    370       4,091                   4,091     $  
Tax benefit of stock-based benefit plans
          1,044                   1,044        
Stock-based compensation expense
          177                   177        
Translation adjustments
                (160 )           (160 )     (160 )
Net income for the period
                      2,848       2,848       2,848  
 
   
 
     
 
     
 
     
 
     
 
     
 
 
Balances, March 31, 2004
    18,644     $ 171,757     $ 3,079     $ (5,846 )   $ 168,990          
 
   
 
     
 
     
 
     
 
     
 
         
Comprehensive income, for the three months ended March 31, 2004
                                          $ 2,688  
 
                                           
 
 


(1)   Income taxes are generally not provided for foreign currency translation adjustments.
 
(2)   For the three months ended March 31, 2003, other comprehensive loss amounted to $4.1 million and consisted of the net loss for the period of $4.2 million, net income from translation adjustments of $72 thousand, and unrealized gain on a security available for sale of $43 thousand.

The accompanying notes are an integral part of these financial statements.

4


Table of Contents

RADISYS CORPORATION

CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands, unaudited)
                 
    For the Three Months Ended March 31,
    2004
  2003
Cash flows from operating activities:
               
Net income (loss)
  $ 2,848     $ (4,246 )
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
               
Loss on sale of Savvi business
          4,286  
Depreciation and amortization
    1,993       2,584  
Provision for inventory reserves
    716       1,291  
Non-cash restructuring (adjustments) charges
    (180 )      
Non-cash interest expense
    136       71  
Non-cash amortization of premium on investments
    475       543  
Loss on disposal of property and equipment
    3       252  
Gain on early extinguishments of convertible subordinated notes
          (825 )
Deferred income taxes
    (106 )     265  
Stock-based compensation expense
    177        
Tax benefit of stock-based benefit plans
    1,044       17  
Other
    (88 )     80  
Changes in operating assets and liabilities:
               
Accounts receivable
    (4,647 )     (2,451 )
Inventories
    3,853       (4,351 )
Other current assets
    (19 )     613  
Accounts payable
    2,099       2,069  
Accrued restructuring
    (466 )     (378 )
Accrued interest payable
    (598 )     (1,168 )
Accrued wages and bonuses
    53       (671 )
Other accrued liabilities
    (420 )     2,056  
 
   
 
     
 
 
Net cash provided by operating activities
    6,873       37  
 
   
 
     
 
 
Cash flows from investing activities:
               
Proceeds from sale or maturity of held-to-maturity investments
    11,780       20,176  
Purchase of held-to-maturity investments
    (2,295 )     (18,547 )
Capital expenditures
    (1,257 )     (468 )
Proceeds from the sale of Savvi business
          360  
 
   
 
     
 
 
Net cash provided by investing activities
    8,228       1,521  
 
   
 
     
 
 
Cash flows from financing activities:
               
Early extinguishments of convertible subordinated notes
          (9,238 )
Principal payments on mortgage payable
          (23 )
Proceeds from issuance of common stock
    4,091       684  
 
   
 
     
 
 
Net cash provided by (used in) financing activities
    4,091       (8,577 )
 
   
 
     
 
 
Effects of exchange rate changes
    (160 )     72  
 
   
 
     
 
 
Net increase (decrease) in cash and cash equivalents
    19,032       (6,947 )
Cash and cash equivalents, beginning of period
    149,925       33,138  
 
   
 
     
 
 
Cash and cash equivalents, end of period
  $ 168,957     $ 26,191  
 
   
 
     
 
 

The accompanying notes are an integral part of these financial statements.

5


Table of Contents

RADISYS CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Note 1 — Significant Accounting Policies

     RadiSys Corporation (the “Company”) has adhered to the accounting policies set forth in its Annual Report on Form 10-K for the year ended December 31, 2003 in preparing the accompanying interim Consolidated Financial Statements. The preparation of these statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue and expenses, and related disclosure of contingent assets and liabilities. Actual results could differ from those estimates.

     The financial information included herein reflects all normal recurring adjustments that are, in the opinion of management, necessary for a fair presentation of the results for interim periods.

     For the three months ended March 31, 2004, there have been no changes to these accounting policies except as noted below.

   Reclassifications

     Certain reclassifications have been made to amounts in prior years to conform to current year presentation. These changes had no effect on previously reported results of operations or shareholders’ equity.

   Inventories

     During the fourth quarter of 2003, the Company revised the excess and obsolete inventory (“E&O”) reserve calculation. The Company previously estimated the required reserve for excess inventory based on a forward projection of excess material beyond 12 months demand. The revised process takes into consideration the historical usage of materials over the prior six months and a prospective view of demand over 12 months. The Company tested the revised method against prior periods and found it to be a better indicator of excess inventory.

   Accrued Restructuring

     In July 2002, the Financial Accounting Standard Board (“FASB”) issued Statement of Financial Accounting Standard (“SFAS”) No. 146 “Accounting for Costs Associated with Exit or Disposal Activities.” SFAS No. 146 requires that liabilities for costs associated with exit or disposal activities be recognized and measured initially at fair value in the period in which the liabilities are incurred. For the year ended December 31, 2003, the Company recorded restructuring charges in accordance with the provisions of SFAS No. 146.

     Prior to the year ended December 31, 2003, the Company recorded restructuring charges including employee termination and related costs, costs related to leased facilities, losses on impairment of fixed assets and capitalized software and other accounting and legal fees. Employee termination and related costs were previously recorded in accordance with the provisions of Emerging Issues Task Force No. 94-3, “Liability Recognition for Certain Employee Termination Benefits and Other Costs to Exit an Activity.” For leased facilities that were vacated and subleased, an amount equal to the total future lease obligations from the date of vacating the premises through the expiration of the lease, net of any future sublease income, was recorded as a part of restructuring charges.

6


Table of Contents

   Warranty

     The Company provides for the estimated cost of product warranties at the time it recognizes revenue. Products are generally sold with warranty coverage for a period of 24 months after shipment. Parts and labor are covered under the terms of the warranty agreement. The warranty provision is based on historical experience by product family. The Company engages in extensive product quality programs and processes, including actively monitoring and evaluating the quality of its components suppliers; however, ongoing failure rates, material usage and service delivery costs incurred in correcting product failure, as well as specific product class failures out of the Company’s baseline experience affect the estimated warranty obligation. If actual product failure rates, material usage or service delivery costs differ from estimates, revisions to the estimated warranty liability would be required.

     The following is a summary of the change in the Company’s warranty liability for the three months ended March 31, 2004 and 2003 (in thousands):

                 
    For the Three Months Ended
    March 31,
    2004
  2003
Warranty liability balance, beginning of the period
  $ 2,276     $ 1,553  
Product warranty accruals
    1,149       1,147  
Adjustments for payments made
    (1,497 )     (781 )
 
   
 
     
 
 
Warranty liability balance, end of the period
  $ 1,928     $ 1,919  
 
   
 
     
 
 

     The warranty liability balance is included in other accrued liabilities in the accompanying Consolidated Balance Sheets as of March 31, 2004 and December 31, 2003. The Company offers fixed price support or maintenance contracts to its customers. Revenues from fixed price support or maintenance contracts were not significant to the Company’s operations for the periods reported.

   Stock-based Compensation

     The Company accounts for its stock-based compensation plans using the intrinsic value method and provides pro forma disclosures of net income (loss) and net income (loss) per common share as if the fair value method had been applied in measuring compensation expense. Equity instruments are not granted to non-employees, other than directors, as defined in the respective plan agreements.

     Had RadiSys accounted for these plans under the fair value method, the Company’s net income (loss) and pro forma net income (loss) per share would have been reported as follows (in thousands, except per share amounts):

                 
    For the Three Months Ended March 31,
    2004
  2003
Net income (loss)
  $ 2,848     $ (4,246 )
Add: Stock-based compensation expense included in reported net income (loss), net of related tax effects
    115        
Deduct: Stock-based compensation expense determined under fair value method for all awards, net of related tax effects
    (1,516 )     (1,668 )
 
   
 
     
 
 
Pro forma net income (loss)
  $ 1,447     $ (5,914 )
 
   
 
     
 
 
Net income (loss) per share:
               
Basic
  $ 0.15     $ (0.24 )
 
   
 
     
 
 
Diluted
  $ 0.15     $ (0.24 )
 
   
 
     
 
 
Pro forma basic
  $ 0.08     $ (0.33 )
 
   
 
     
 
 
Pro forma diluted
  $ 0.07     $ (0.33 )
 
   
 
     
 
 

     During the three months ended March 31, 2004, the Company incurred $177 thousand of stock-based compensation expense associated with shares to be issued pursuant to the Company’s 1996 Employee Stock Purchase Plan (“ESPP”). The Company incurred stock-based compensation expense because the original number of ESPP shares approved by the shareholders will be insufficient to meet employee demand for an ESPP offering

7


Table of Contents

which was consummated in February 2003 and ends in August 2004. The Company subsequently received shareholder approval for additional ESPP shares in May 2003. The shares to be issued in the February 2003 ESPP offering in excess of the original number of ESPP shares approved at the beginning of the offering (the “shortfall”) triggers recognition of stock-based compensation expense under the intrinsic value method. The Company currently estimates the shortfall to amount to 121 thousand shares and 138 thousand shares to be issued in May 2004 and August 2004, respectively.

     The expense per share is calculated as the difference between 85% of the closing price of RadiSys shares as quoted on NASDAQ on the date that additional ESPP shares were approved (May 2003) and the February 2003 ESPP offering purchase price. Accordingly, the expense per share is calculated as the difference between $8.42 and $5.48. The shortfall of shares is dependent on the amount of contributions from participants enrolled in the February 2003 ESPP offering.

     The Company recognized stock-based compensation expense as follows (in thousands):

                 
    For the Three Months Ended March 31,
    2004
  2003
Cost of sales
  $ 47     $  
Research and development
    74        
Selling, general and administrative
    56        
 
   
 
     
 
 
 
  $ 177     $  
 
   
 
     
 
 

     For the three months ended June 30, 2004 and September 30, 2004, the Company estimates stock-based compensation expense recognized under the intrinsic value method to amount to $380 thousand and $200 thousand, respectively.

   Recent Accounting Pronouncements

     In March 2004, the Emerging Issues Task Force (“EITF”) finalized it consensus on EITF Issue 03-6, “Participating Securities and the Two-Class Method Under SFAS No. 128, Earnings Per Share” ( “EITF 03-6”). EITF 03-6 clarifies what constitutes a participating security and requires the use of the two-class method for computing basic earnings per share when participating convertible securities exist. EITF 03-6 is effective for fiscal periods beginning after March 31, 2004. The Company does not expect the adoption of EITF 03-6 to have a material impact on the Company’s financial position, results of operations or cash flows.

Note 2 — Held-to-maturity Investments

     Held-to-maturity investments consisted of the following (in thousands):

                 
    March 31,   December 31,
    2004
  2003
Short-term held-to-maturity investments, including unamortized premium of $671 and $767, respectively
  $ 41,629     $ 44,456  
 
   
 
     
 
 
Long-term held-to-maturity investments, including unamortized premium of $209 and $442, respectively
  $ 23,859     $ 30,992  
 
   
 
     
 
 

     As of March 31, 2004, the Company’s long-term held-to-maturity investments had maturities ranging from 13.5 months to 28.8 months. The Company’s investment policy requires that the total investment portfolio, including cash and investments, not exceed a maximum weighted-average maturity of 18 months. In addition, the policy mandates that an individual investment must have a maturity of less than 36 months, with no more than 20% of the total portfolio exceeding 24 months. As of March 31, 2004, the Company was in compliance with its investment policy.

8


Table of Contents

Note 3 — Accounts Receivable

     Accounts receivable balances consisted of the following (in thousands):

                 
    March 31,   December 31,
    2004
  2003
Accounts receivable, gross
  $ 37,981     $ 33,445  
Less: allowance for doubtful accounts
    (1,190 )     (1,301 )
 
   
 
     
 
 
Accounts receivable, net
  $ 36,791     $ 32,144  
 
   
 
     
 
 

     The Company recorded no provisions for allowance for doubtful accounts during the three months ended March 31, 2004 and 2003.

Note 4 — Inventories

     Inventories consisted of the following (in thousands):

                 
    March 31,   December 31,
    2004
  2003
Raw materials
  $ 24,692     $ 28,992  
Work-in-process
    1,956       1,472  
Finished goods
    3,666       5,119  
 
   
 
     
 
 
 
    30,314       35,583  
Less: inventory reserves
    (8,791 )     (9,491 )
 
   
 
     
 
 
Inventories, net
  $ 21,523     $ 26,092  
 
   
 
     
 
 

     During the three months ended March 31, 2004 and 2003, the Company recorded provision for excess and obsolete inventory of $716 thousand and $1.3 million, respectively.

     The following is a summary of the change in the Company’s excess and obsolete inventory reserve for the three months ended March 31, 2004 and 2003 (in thousands):

                 
    For the Three Months Ended
    March 31,
    2004
  2003
Inventory reserve balance, beginning of the quarter
  $ 9,491     $ 9,958  
Usage:
               
Inventory scrapped
    (667 )     (185 )
Inventory utilized
    (749 )     (649 )
 
   
 
     
 
 
Subtotal — usage
    (1,416 )     (834 )
Reserve provision
    716       1,291  
 
   
 
     
 
 
Remaining reserve balance, end of the quarter
  $ 8,791     $ 10,415  
 
   
 
     
 
 

Note 5 — Goodwill

     During the three months ended March 31, 2003 the Company recorded goodwill write-offs of $2.4 million associated with the sale of its Savvi business line. The goodwill write-off associated with the sale of the Savvi business line is included in loss from discontinued operations in the accompanying Consolidated Statements of Operations for the three months ended March 31, 2003. See Note 13.

     The Company tests goodwill for impairment at least annually. Additionally, the Company assesses goodwill for impairment if any adverse conditions exist that would indicate an impairment. Conditions that would trigger an impairment assessment, include, but are not limited to, a significant adverse change in legal factors or in the business climate that could affect the value of an asset or an adverse action or assessment by a regulator. If the carrying amount of an asset exceeds the sum of its undiscounted cash flows, the carrying value is written down to fair value in the period identified. Fair value is calculated as the present value of estimate future cash flows using a risk-adjusted discount rate commensurate with the Company’s weighted-average cost of capital. The Company

9


Table of Contents

completed its annual goodwill impairment analysis as of September 30, 2003 and concluded that as of September 30, 2003, there was no goodwill impairment. Management concluded there was no indication of material changes requiring an updated goodwill impairment analysis as of March 31, 2004.

10


Table of Contents

Note 6 — Intangible Assets

     The following tables summarize details of the Company’s total purchased intangible assets (in thousands):

                         
            Accumulated    
    Gross
  Amortization
  Net
March 31, 2004
                       
Existing technology
  $ 2,415     $ (1,223 )   $ 1,192  
Technology licenses
    6,790       (3,961 )     2,829  
Patents
    6,647       (5,465 )     1,182  
Trade names
    736       (184 )     552  
Other
    237       (237 )      
 
   
 
     
 
     
 
 
Total
  $ 16,825     $ (11,070 )   $ 5,755  
 
   
 
     
 
     
 
 
                         
            Accumulated    
    Gross
  Amortization
  Net
December 31, 2003
                       
Existing technology
  $ 2,415     $ (1,146 )   $ 1,269  
Technology licenses
    6,790       (3,584 )     3,206  
Patents
    6,647       (5,255 )     1,392  
Trade names
    736       (166 )     570  
Other
    237       (237 )      
 
   
 
     
 
     
 
 
Total
  $ 16,825     $ (10,388 )   $ 6,437  
 
   
 
     
 
     
 
 

     The Company’s purchased intangible assets have lives ranging from 4 to 11 years. The Company performs reviews for impairment of all its purchased intangible assets whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. As of March 31, 2004, management concluded there was no indication of events or changes in circumstances indicating that the carrying amount of purchased intangible assets may not be recoverable. The estimated future amortization expense of purchased intangible assets as of March 31, 2004 is as follows (in thousands):

         
    Estimated
    Intangible
    Amortization
For the years ending December 31,
  Amount
2004 (remaining nine months)
  $ 1,543  
2005